Announced Mon, 22 Jun · 16:56 IST
Board meeting on July 22, 2026 to consider Q1 FY27 results
Results View source PDF
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.7%1-day move
₹1292.80
prior close
₹1297.20
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+1.0+1.4+2.1+2.7+4.4+6.7+5.1+3.6+6.1-4.9-9.5——
Up moveDown movePending
AI summary
The Board of Directors of Dr Reddys Laboratories will meet on Wednesday, July 22, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026 (Q1 FY27). The trading window for dealing in company securities is closed from June 24, 2026 to July 24, 2026, both days inclusive, in line with insider trading rules. This is a standard regulatory intimation under SEBI LODR Regulation 29.
Likely market impact
Routine filing. Q1 FY27 results on July 22 may move the stock depending on numbers; insider trading window is now closed.